Noren et al. [95] reported that treatment of breast cancer cells with Ephrin-B2 Fc increased CrkII phosphorylation on Tyr221 in an Abl-dependent manner, leading to inhibition of cell motility and invasion. The gene discussed is CRK; the disease is breast cancer.